These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10217343)

  • 41. Pharmacokinetics of oxcarbazepine in the dog.
    Schicht S; Wigger D; Frey HH
    J Vet Pharmacol Ther; 1996 Feb; 19(1):27-31. PubMed ID: 8992022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid.
    Spiegelstein O; Yagen B; Levy RH; Finnell RH; Bennett GD; Roeder M; Schurig V; Bialer M
    Pharm Res; 1999 Oct; 16(10):1582-8. PubMed ID: 10554101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers.
    Nunes T; Rocha JF; Falcão A; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Jan; 54(1):108-16. PubMed ID: 22812691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models.
    Fortuna A; Alves G; Soares-da-Silva P; Falcão A
    Epilepsy Res; 2013 Nov; 107(1-2):37-50. PubMed ID: 24050973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overview of the clinical pharmacokinetics of oxcarbazepine.
    Flesch G
    Clin Drug Investig; 2004; 24(4):185-203. PubMed ID: 17516704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of the individual enantiomers of cis-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]-benzamide monohydrochloride (U-54494A) in the dog.
    Zhong WZ; Williams MG; Schuette MR; Vandegiessen TL; Jones BW
    Enantiomer; 1996; 1(2):89-96. PubMed ID: 9676281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of the enantiomers of verapamil after intravenous and oral administration of racemic verapamil in a rat model.
    Bhatti MM; Foster RT
    Biopharm Drug Dispos; 1997 Jul; 18(5):387-96. PubMed ID: 9210977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy.
    Yu Y; Zhang Q; Xu W; Lv C; Hao G
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):345-51. PubMed ID: 25700977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
    Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK
    Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Therapeutic drug monitoring of oxcarbazepine].
    Bouquié R; Dailly E; Bentué-Ferrer D;
    Therapie; 2010; 65(1):61-5. PubMed ID: 20205998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stereoselective pharmacokinetics of bisoprolol after intravenous and oral administration in beagle dogs.
    Horikiri Y; Suzuki T; Mizobe M
    J Pharm Sci; 1997 May; 86(5):560-4. PubMed ID: 9145379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy.
    Rey E; Bulteau C; Motte J; Tran A; Sturm Y; D'Souza J; Markabi S; Pons G; Dulac O
    J Clin Pharmacol; 2004 Nov; 44(11):1290-300. PubMed ID: 15496647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous stereoselective high-performance liquid chromatographic determination of 10-hydroxycarbazepine and its metabolite carbamazepine-10,11-trans-dihydrodiol in human urine.
    Volosov A; Bialer M; Xiaodong S; Perucca E; Sintov A; Yagen B
    J Chromatogr B Biomed Sci Appl; 2000 Feb; 738(2):419-25. PubMed ID: 10718660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of the R-(-) and S-(+) enantiomers of the monohydroxylated metabolite of oxcarbazepine in human plasma by enantioselective high-performance liquid chromatography.
    Flesch G; Francotte E; Hell F; Degen PH
    J Chromatogr; 1992 Oct; 581(1):147-51. PubMed ID: 1429999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid.
    Tartara A; Galimberti CA; Manni R; Morini R; Limido G; Gatti G; Bartoli A; Strada G; Perucca E
    Br J Clin Pharmacol; 1993 Oct; 36(4):366-8. PubMed ID: 12959317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stereoselective pharmacokinetics of methadone in beagle dogs.
    Schmidt N; Brune K; Williams KM; Geisslinger G
    Chirality; 1994; 6(6):492-5. PubMed ID: 7946975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy.
    Li X; Wei S; Wu H; Zhang Q; Zhao Z; Mei S; Feng W; Wu Y
    Eur J Pediatr; 2023 Oct; 182(10):4509-4521. PubMed ID: 37493972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of efflux transporters and of seizures on the pharmacokinetics of oxcarbazepine metabolite in the rat brain.
    Clinckers R; Smolders I; Michotte Y; Ebinger G; Danhof M; Voskuyl RA; Della Pasqua O
    Br J Pharmacol; 2008 Dec; 155(7):1127-38. PubMed ID: 18836479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy.
    Sattler A; Schaefer M; May TW
    Seizure; 2015 Sep; 31():149-54. PubMed ID: 26362393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical pharmacology and pharmacokinetics of oxcarbazepine.
    Lloyd P; Flesch G; Dieterle W
    Epilepsia; 1994; 35 Suppl 3():S10-3. PubMed ID: 8156973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.